These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2836003)

  • 21. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoetic precursors respond to a unique B lymphocyte-derived factor in vivo.
    Niskanen E; Gorman J; Isakson PC
    Blood; 1987 Dec; 70(6):1784-9. PubMed ID: 2823936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
    Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
    Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The growth of Rauscher erythroleukemia cells is mediated by autocrine production of a factor with biological activity similar to interleukin-3.
    Migliaccio G; Migliaccio AR; Ruscetti S; Adamson JW
    Blood; 1989 May; 73(7):1770-7. PubMed ID: 2653464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of activin A on globin gene expression in purified human erythroid progenitors.
    Shao L; Frigon NL; Young AL; Yu AL; Mathews LS; Vaughan J; Vale W; Yu J
    Blood; 1992 Feb; 79(3):773-81. PubMed ID: 1310063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.
    Hirase N; Yanase T; Mu Y; Muta K; Umemura T; Takayanagi R; Nawata H
    Leuk Res; 2000 May; 24(5):393-400. PubMed ID: 10785261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor.
    Parodi MT; Tonini GP; Bologna R; Franchini E; Cornaglia-Ferraris P
    Boll Ist Sieroter Milan; 1988; 67(2):142-8. PubMed ID: 3228498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3: studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures.
    Sonoda Y; Yang YC; Wong GG; Clark SC; Ogawa M
    Blood; 1988 Oct; 72(4):1381-6. PubMed ID: 3048444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone polypeptides stimulate proliferation of K562 human erythroleukemia cells.
    Gauwerky C; Golde DW; Li CH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1208-10. PubMed ID: 6448265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum.
    Hicks DG; Ohlsson-Wilhelm BM; Farley BA; Kosciolek BA; Rowley PT
    Exp Hematol; 1985 May; 13(4):273-80. PubMed ID: 3921391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple differentiation programs in K562 erythroleukemia cells and their regulation.
    Horton MA; Cedar SH; Maryanka D; Mills FC; Turberville C
    Prog Clin Biol Res; 1983; 134():305-22. PubMed ID: 6582521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.
    Strife A; Lambek C; Wisniewski D; Gulati S; Gasson JC; Golde DW; Welte K; Gabrilove JL; Clarkson B
    Blood; 1987 May; 69(5):1508-23. PubMed ID: 3494480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a K562 multidrug-resistant cell line.
    Yanovich S; Hall RE; Gewirtz DA
    Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythroid potentiating activity enhances the effect of erythropoietin in mice.
    Niskanen E; Gasson JC; Egrie J; Wipf K; Golde DW
    Eur J Haematol; 1990 Nov; 45(5):267-70. PubMed ID: 2261953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth and differentiation of human and murine erythroleukemia cell lines in serum-free synthetic medium.
    Pessano S; McNab A; Rovera G
    Cancer Res; 1981 Sep; 41(9 Pt 1):3592-6. PubMed ID: 7020933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport.
    Matherly LH; Czajkowski CA; Angeles SM
    Cancer Res; 1991 Jul; 51(13):3420-6. PubMed ID: 2054782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
    Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of the specific binding of bovine transferrin to the human transferrin receptor in K562 cells: evidence for interspecies transferrin internalization.
    Tsavaler L; Stein BS; Sussman HH
    J Cell Physiol; 1986 Jul; 128(1):1-8. PubMed ID: 3013902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.
    He R; Liu B; Yang C; Yang RC; Tobelem G; Han ZC
    Cancer Gene Ther; 2003 Dec; 10(12):879-86. PubMed ID: 14712314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.